| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 03/26/2009 | WO2009038795A2 Positron emission tomography probes for imaging immune activation and selected cancers |
| 03/26/2009 | WO2009038776A1 Therapeutic nanoconjugates |
| 03/26/2009 | WO2009038659A2 Organically modified silica nanoparticles with covalently incorporated photosensitizers for drug delivery in photodynamic therapy |
| 03/26/2009 | WO2009037857A1 Diagnostic agent and therapeutic agent for lung cancer, prostate cancer, breast cancer, ovarian cancer or melanoma |
| 03/26/2009 | WO2009037336A2 Improved radiopharmaceutical composition |
| 03/26/2009 | WO2008127743A3 Composition for targeted drug delivery and controlled release |
| 03/26/2009 | WO2005094553A3 Compositions for promoting bone growth and methods thereof |
| 03/26/2009 | US20090081660 Compositions and methods for the diagnosis and treatment of tumor |
| 03/26/2009 | US20090081209 Methods of therapy and diagnosis using targeting of cells that express killer cell immunoglobulin-like receptor-like proteins |
| 03/26/2009 | US20090081185 Apoptotic agents |
| 03/26/2009 | US20090081127 Dendritic-like cell/tumor cell hybrids and hybridomas for inducing an anti-tumor response |
| 03/26/2009 | US20090081123 Pharmaceutical compounds |
| 03/26/2009 | US20090081122 Injectable superparamagnetic nanoparticles for treatment by hyperthermia and use for forming an hyperthermic implant |
| 03/26/2009 | US20090081121 Liposome compositions useful for tumor imaging and treatment |
| 03/26/2009 | US20090081120 Methods and Compositions for Increasing Patient Tolerability During Myocardial Imaging Methods |
| 03/26/2009 | US20090081119 Inhibiting dna polymerase beta to enhance efficacy of anticancer agents |
| 03/26/2009 | CA2699967A1 Positron emission tomography probes for imaging immune activation and selected cancers |
| 03/26/2009 | CA2699912A1 Method for imaging and treating organs and tissues |
| 03/26/2009 | CA2699394A1 Internalizing human monoclonal antibodies targeting prostate cancer cells in situ |
| 03/25/2009 | EP1554734B1 Stabilized superparamagnetic particles |
| 03/25/2009 | EP1492452A4 System, formulation, kit and method for tagging colonic residue in an individual |
| 03/25/2009 | CN100471523C Radiopharmaceutical formulations |
| 03/24/2009 | US7507835 e.g. [2-(1-(Benzenesulfonyl)-1H-indol-3-yloxy)ethyl]dimethylamine; serotonin, melatonin receptor ligand; antidepressant, anxiolytic agent; cognition activator; psychosis, schizophrenia, migraine headache, drug addiction, convulsions, osteoporosis, ischemic stroke, Alzheimer's, Parkinson's diseases |
| 03/24/2009 | US7507790 Plurality of peptide monomers each being attached at one end to a hub capable of interacting with a sub-unit of a self-assembling peptide to form an overlapping staggered structure or protein; purification of blood or biological fluids, cell assembly and tissue engineering |
| 03/24/2009 | US7507719 Use of peptidic conjugates for preparing compositions for alopecia preventive and curative treatment |
| 03/24/2009 | US7507708 Particularly Kahalalide F, a tridecapeptide with a ring shape side and a lateral side amidated with 5-methylhexanoic acid; anticarcinogenic agent; refractory cancer that does not respond favorably to other treatments; peptides isolated mollusc, Elysia Elysia rufescens and its diet, a green algae |
| 03/24/2009 | US7507556 Expresion vector comprising nucleotide sequences coding membrane protein for use in diagnosis, prevention and treatment of cell adhesion, proliferation, inflammatory disorders; wound healing agents |
| 03/24/2009 | US7507541 36P6D5: secreted tumor antigen |
| 03/24/2009 | US7507537 Cytotoxicity mediation of cells evidencing surface expression of CD44 |
| 03/24/2009 | US7507400 Water soluble depilatory having extended shelf life |
| 03/24/2009 | CA2450690C Improved chelator conjugates |
| 03/24/2009 | CA2215997C Biodegradable polyacetal polymers and formation and use |
| 03/19/2009 | WO2009035959A2 Radiofluorination methods |
| 03/19/2009 | WO2009035157A1 Therapeutic and/or prophylactic agent for lower urinary tract symptoms after radiotherapy |
| 03/19/2009 | WO2009033876A1 Aptamers labeled with 18f |
| 03/19/2009 | WO2009033584A2 Diagnostic agents for positron emission imaging using f-18 radio-labeled amino-alcohols |
| 03/19/2009 | WO2009033259A1 An anti-cancer cytotoxic monoclonal antibody |
| 03/19/2009 | US20090074664 Cyclic azapeptides as integrin markers |
| 03/19/2009 | US20090074663 Peptide for diagnosing, preventing and treating atherosclerosis and uses thereof |
| 03/19/2009 | US20090074662 Cancerous Disease modifying antibodies |
| 03/19/2009 | US20090074661 Anti-il-22ra antibodies and binding partners and methods of using in inflammation |
| 03/19/2009 | US20090074660 Human Monoclonal Antibodies To O8E |
| 03/19/2009 | US20090074659 Cancerous disease modifying antibodies |
| 03/19/2009 | US20090074658 Compositions and methods for generating and screening adenoviral libraries |
| 03/19/2009 | US20090074657 Nucleotide and protein sequences of an antibody directed against an epitope common to human acidic and basic ferritins, monoclonal antibodies or antibody-like molecules comprising these sequences and uses thereof |
| 03/19/2009 | US20090072169 Leak Resistant Syringe Cover |
| 03/18/2009 | EP2036981A1 Aptamers labeled with 18F |
| 03/18/2009 | EP2036578A1 Diagnostic agents for positron emission imaging using F-18 radio labeled amino-alcohols |
| 03/18/2009 | EP2035421A1 2-ARYLPYRAZOLO[L,5-alpha]PYRIMIDIN-3-YL ACETAMIDE DERIVATIVES AS LIGANDS FOR TRANSLOCATOR PROTEIN (18 KDA) |
| 03/18/2009 | EP2035007A1 Use of adenosine a1 antagonist in radiocontrast media induced nephropathy |
| 03/18/2009 | EP2000154A9 Composition for preparation of radioactive pharmaceutical for diagnosis of regional cerebral blood flow |
| 03/18/2009 | EP1673492B1 Radium target and method for producing it |
| 03/18/2009 | EP1581262B1 Contrast agent |
| 03/18/2009 | EP1517918B1 Peptides having affinity for a phospholipid and uses |
| 03/18/2009 | EP1503804A4 Radiopharmaceutical formulations |
| 03/18/2009 | CN101389355A Bifunctional resorcinol, thioresorcinol, and dithioresorcinol derivative metal chelating conjugates |
| 03/18/2009 | CN100469788C 糖肽膦酸盐衍生物 Glycopeptide phosphonate derivatives |
| 03/18/2009 | CN100469781C Technetium-99m marked double phospho acid compound |
| 03/17/2009 | US7504233 Reliable measure of insulin resistance; kits |
| 03/17/2009 | US7504208 Deblocking, deprotecting 18F-labeled tracer; ion exchange chromatography; cartrigdes, radiopharmaceutical kits; diagnostic positron emission tomography; pharmacokinetics |
| 03/17/2009 | US7504087 Receptor-avid exogenous optical contrast and therapeutic agents |
| 03/17/2009 | US7504086 Structure and method for releasing substance therefrom |
| 03/12/2009 | WO2009033094A2 Antibodies and related molecules that bind to 24p4c12 proteins |
| 03/12/2009 | WO2009032160A2 Metalloprotein mri contrast agents and related methods |
| 03/12/2009 | WO2009031712A1 Compound, diagnostic agent, nuclear magnetic resonance analysis method, nuclear magnetic resonance imaging method, mass spectrometry method and mass spectrometry imaging method |
| 03/12/2009 | WO2008136850A3 Cobalamin conjugates useful as imaging and therapeutic agents |
| 03/12/2009 | WO2006135374A3 Rubidium-82 generator based on sodium nonatitanate support, and improved separation methods for the recovery of strontium-82 from irradiated targets |
| 03/12/2009 | WO2006020266A3 Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof |
| 03/12/2009 | US20090069225 Somatostatin analogues |
| 03/12/2009 | US20090068105 Isatin analogues and uses therefor |
| 03/12/2009 | US20090068104 Substantially Homogeneous Bio-Affecting Material Having a Pre-Determined Ratio of Bioaffecting Component to Cell Targeting Component, the Method for Making Such a Material and the Method of its use |
| 03/12/2009 | US20090068103 Aptamers labeled with 68ga |
| 03/12/2009 | US20090068102 Treating stroke |
| 03/12/2009 | US20090068100 Cancerous disease modifying antibodies |
| 03/12/2009 | US20090068099 Cancerous disease modifying antibodies |
| 03/12/2009 | US20090068098 Antibodies and related molecules that bind to 58p1d12 proteins |
| 03/12/2009 | US20090068097 Method for non-invasive detection and treatment of cerebral aneurysms |
| 03/12/2009 | US20090068096 Sequence of stro-1 antibody variable region |
| 03/12/2009 | US20090068095 Carbonic anhydrase ix (g250) anitbodies and methods of use thereof |
| 03/12/2009 | US20090068094 Inhibitors of endo-exonuclease activity for treating cancer |
| 03/12/2009 | CA2698287A1 Antibodies and related molecules that bind to 24p4c12 proteins |
| 03/12/2009 | CA2697504A1 Salicylanilide modified peptides for use as oral therapeutics |
| 03/11/2009 | EP2032590A1 Triazole containing metal chelating agents |
| 03/11/2009 | EP2032512A1 Radiolabelled ligand for the glycine 1 transporter |
| 03/11/2009 | EP1517919B1 Marked peptides having affinity for a phospholipid and uses |
| 03/11/2009 | EP0977579B1 Gastrin receptor-avid peptide conjugates |
| 03/11/2009 | CN101384578A Radioligands for the 5 -ht1b receptor |
| 03/11/2009 | CN101381296A Method for synthesizing carbon nuclide (<11>C) labeled acetate |
| 03/10/2009 | US7501498 Moncolonal antibody for use in diagnosis and treatment of cell proliferative disorders; immunotherapy; tissue engineering |
| 03/10/2009 | CA2342210C Thiazoline acid derivatives |
| 03/05/2009 | WO2009029727A1 Cannabinoid receptor targeted agent |
| 03/05/2009 | WO2009027707A2 Methods for preparing peptides, especially radio-labelled peptides |
| 03/05/2009 | WO2009027706A2 Radiolabeled monomeric and multimeric cyclic oligopeptides binding to the cxcr4 receptor for cancer imaging and treatment |
| 03/05/2009 | WO2009027690A1 Diagnostic agent |
| 03/05/2009 | WO2009027452A2 Radiopharmaceutical composition |
| 03/05/2009 | WO2009026692A1 An anti-cancer cytotoxic monoclonal antibody |
| 03/05/2009 | US20090060865 Mammalian receptor proteins; related reagents and methods |
| 03/05/2009 | US20090060838 Substituted n-aryl benzamides and related compounds for treatment of amyloid diseases and synucleinopathies |
| 03/05/2009 | US20090060837 Cobalamin conjugates useful as antitumor agents |
| 03/05/2009 | US20090060836 Derivatives of 2-nitro-1,3-imidazole coupled to amino acids and deoxyribose useful for the detection of hypoxic biological tissue |